Henk-Jan B.
- Country
- The Netherlands
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 52 partner sites.
Specializations
Hematologic Oncology
Dr. Boiten’s work centers on hematologic malignancies, with a particular focus on B‑cell lymphoma, chronic lymphocytic leukemia, multiple myeloma and T‑cell prolymphocytic leukemia.
- Investigating novel agents for diffuse large B‑cell lymphoma
- Targeted therapy development in follicular lymphoma
- Combination regimens for relapsed chronic lymphocytic leukemia
- Immunotherapy approaches in multiple myeloma
- Precision medicine for T‑cell prolymphocytic leukemia
Collaboration with national cancer networks supports rapid translation of discoveries.
Solid Tumor Oncology
The investigator addresses major solid cancers including prostate cancer, renal cell carcinoma, non‑small cell lung cancer, breast cancer, colorectal cancer and bladder cancer.
- Therapeutic strategies for metastatic castration‑resistant prostate cancer
- Targeted treatment of clear cell renal cell carcinoma
- Immunomodulatory approaches in advanced non‑small cell lung cancer
- Adjuvant trials for early‑stage breast cancer
- Precision oncology in molecularly defined colorectal cancer
Emphasis is placed on integrating immunotherapy with established modalities.
Cardiovascular & Metabolic Medicine
His portfolio includes conditions such as atherosclerotic cardiovascular disease, atrial fibrillation, stroke, obesity, type 2 diabetes mellitus and non‑alcoholic steatohepatitis.
- Evaluation of lipid‑lowering agents in high cardiovascular risk patients
- Anticoagulation outcomes in atrial fibrillation with transient stress triggers
- Impact of weight‑loss therapies on obesity‑related metabolic disease
- Cardiovascular safety of novel agents in type 2 diabetes mellitus
- Fibrosis regression studies in non‑alcoholic steatohepatitis
He engages in multidisciplinary heart‑kidney research initiatives.
Renal & Immunology
Dr. Boiten investigates kidney‑related disorders, notably chronic kidney disease, immunoglobulin A nephropathy, end‑stage kidney disease and patients undergoing dialysis.
- Proteinuria reduction strategies in IgA nephropathy
- Cardiovascular outcome trials in dialysis populations
- Renal function preservation with novel anti‑inflammatory agents
- Biomarker‑guided therapy in chronic kidney disease
- Immunomodulation approaches for end‑stage kidney disease patients
Collaboration with transplant units facilitates translational research.
Respiratory & Inflammatory Diseases
His interests extend to airway and gut inflammation, covering severe asthma, chronic obstructive pulmonary disease, Crohn's disease, ulcerative colitis and rheumatoid arthritis.
- Biologic therapy optimization for eosinophilic severe asthma
- Long‑term outcomes of novel bronchodilators in chronic obstructive pulmonary disease
- Targeted treatment pathways for moderately to severely active Crohn's disease
- Maintenance strategies in ulcerative colitis
- Immune‑modulating agents for rheumatoid arthritis
Participation in patient‑reported outcome studies enhances therapeutic relevance.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.